TC
COLL icon

TFS Capital’s Collegium Pharmaceutical COLL Stock Holding History

TFS Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-22,577
Closed -$352K – 694
2016
Q4 		$352K Sell
22,577
-11,334
-33% -$188K 0.09% 372
2016
Q3 		$653K Sell
33,911
-14,625
-30% -$174K 0.16% 194
2016
Q2 		$575K Sell
48,536
-79,032
-62% -$1.31M 0.11% 344
2016
Q1 		$2.31M Buy
+127,568
New +$2.32M 0.33% 28

Other funds holding COLL

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TFS Capital's COLL Position: Q1 2017 in Review

TFS Capital sold out of Collegium Pharmaceutical (COLL) in Q1 2017, closing a stake of 22,577 shares — an estimated $352K sold.

TFS Capital first reported a position in COLL in Q1 2016 and held it in 4 quarters. The position peaked at $2.31M in Q1 2016. 83 funds tracked by Wall St. Rank hold COLL as of Q1 2017.

  • TFS Capital reported no remaining Collegium Pharmaceutical position as of Q1 2017 after selling out during the quarter.
  • TFS Capital sold 22,577 Collegium Pharmaceutical shares in Q1 2017, an estimated $352K.
  • TFS Capital first reported a position in Collegium Pharmaceutical in Q1 2016 and held it in 4 quarters.
  • TFS Capital's Collegium Pharmaceutical position peaked at $2.31M in Q1 2016.
  • 83 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2017.

Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.